HealthMore in Health→
Low-dose cancer therapy study points to access gains
A report highlighted ultra-low-dose immunotherapy as a possible way to widen access to expensive cancer treatment in poorer countries.
Key Takeaways
- STAT highlighted ultra-low-dose immunotherapy as a potential way to cut treatment costs.
- The candidate frames the development around improved access in poorer countries.
DE
DT Editorial Team··via statnews.com